EMFAT
DRNA
Emerald Mutual Fund Advisers Trust’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-223,213
| Closed | -$4.5M | – | 243 |
|
|
2021
Q3 | $4.5M | Sell |
223,213
-238,633
| -52% | -$4.81M | 0.16% | 129 |
|
|
2021
Q2 | $17.2M | Sell |
461,846
-2,412
| -0.5% | -$90K | 0.56% | 74 |
|
|
2021
Q1 | $11.9M | Buy |
464,258
+2,300
| +0.5% | +$58.8K | 0.39% | 97 |
|
|
2020
Q4 | $10.2M | Buy |
461,958
+110,089
| +31% | +$2.43M | 0.35% | 102 |
|
|
2020
Q3 | $6.33M | Buy |
351,869
+4,458
| +1% | +$80.2K | 0.28% | 94 |
|
|
2020
Q2 | $8.82M | Sell |
347,411
-134,590
| -28% | -$3.42M | 0.42% | 84 |
|
|
2020
Q1 | $8.85M | Sell |
482,001
-179,051
| -27% | -$3.29M | 0.56% | 64 |
|
|
2019
Q4 | $14.6M | Sell |
661,052
-117,464
| -15% | -$2.59M | 0.59% | 65 |
|
|
2019
Q3 | $11.2M | Sell |
778,516
-65,379
| -8% | -$939K | 0.49% | 74 |
|
|
2019
Q2 | $13.3M | Sell |
843,895
-47,593
| -5% | -$750K | 0.53% | 72 |
|
|
2019
Q1 | $13.1M | Sell |
891,488
-11,951
| -1% | -$175K | 0.52% | 62 |
|
|
2018
Q4 | $9.66M | Sell |
903,439
-5,781
| -0.6% | -$61.8K | 0.45% | 83 |
|
|
2018
Q3 | $13.9M | Buy |
909,220
+382,361
| +73% | +$5.83M | 0.47% | 84 |
|
|
2018
Q2 | $6.45M | Buy |
526,859
+375,288
| +248% | +$4.6M | 0.23% | 141 |
|
|
2018
Q1 | $1.45M | Sell |
151,571
-419,290
| -73% | -$4.01M | 0.06% | 209 |
|
|
2017
Q4 | $5.16M | Buy |
+570,861
| New | +$5.16M | 0.2% | 147 |
|
|
2015
Q3 | – | Sell |
-125,000
| Closed | -$1.74M | – | 289 |
|
|
2015
Q2 | $1.74M | Buy |
125,000
+70,416
| +129% | +$982K | 0.13% | 144 |
|
|
2015
Q1 | $1.21M | Buy |
54,584
+24,094
| +79% | +$535K | 0.1% | 157 |
|
|
2014
Q4 | $502K | Buy |
+30,490
| New | +$502K | 0.04% | 186 |
|